Abivax S.A. (AAVXF) Financials

AAVXF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 627.0 million 134.7 million
Dec. 31, 2025 685.7 million 151.5 million
Sept. 30, 2025 765.2 million 165.2 million
June 30, 2025 141.0 million 197.9 million

AAVXF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -58.0 million 25.9 million
Dec. 31, 2025 -83.7 million -12.9 million
Sept. 30, 2025 -83.6 million 13.5 million
June 30, 2025 -78.6 million 13.0 million

AAVXF Net Income

No data available :(

AAVXF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - 1.7 million
Dec. 31, 2025 622.4 million 35.5 million 650131
Sept. 30, 2025 - - 1.8 million
June 30, 2025 71.8 million 57.7 million 2.2 million

AAVXF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 90.9 million
Dec. 31, 2025 81.6 million
Sept. 30, 2025 91.3 million
June 30, 2025 74.7 million

AAVXF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 61881 56.8 million 9.2 million -
Dec. 31, 2025 9391 117.1 million 32.5 million 24653
Sept. 30, 2025 - 65.0 million 32.1 million -
June 30, 2025 74255 91.9 million 21.0 million 1.8 million

AAVXF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 -2.4 million 1.3 million
Sept. 30, 2025 - -
June 30, 2025 2.4 million -

AAVXF

Price: $101.25

52 week price:
7.21
133.40

Earnings Per Share: -5.36 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.7 billion

Links: